Exelixis | EXEL - 자기 자본과 준비금





자기 자본과 준비금 변화 날짜
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 25.95B 3.75B 2025-12
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Exelixis USD 2.16B 619K 2025-12
Genmab DKK 5.85B 96M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
MacroGenics USD 55.59M 11.41M 2025-12
Merck USD 45.88B 6.73B 2026-03
Moderna USD 7.41B 1.24B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sanofi EUR 71.71B 14.25B 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Ultragenyx Pharmaceutical USD -80M 89.16M 2025-12
Xencor USD 635.59M 10.27M 2025-12